Use of a Scalable Replicon-Particle Vaccine to Protect Against Lethal Lassa Virus Infection in the Guinea Pig Model.

Use of a Scalable Replicon-Particle Vaccine to Protect Against Lethal Lassa Virus Infection in the Guinea Pig Model.
复制标题

DOI:
10.1093/infdis/jiy123
复制
发表时间:
2018-05-25
期刊:
The Journal of infectious diseases
影响因子:
--
通讯作者:
Spiropoulou CF
Spiropoulou CF
中科院分区:
其他
文献类型:
--
作者:
Kainulainen MH;Spengler JR;Welch SR;Coleman-McCray JD;Harmon JR;Klena JD;Nichol ST;Albariño CG;Spiropoulou CF

文献摘要

参考文献

被引文献

相似文献

拉沙热是一种病毒性人畜共患病,可以在人与人之间传播,特别是在医院环境中。该疾病是西非几个国家的地方病,可能是受影响地区发病率和死亡率的主要原因。没有批准的疫苗来预防拉沙病毒感染。在这项工作中,我们提出了一种候选疫苗,它结合了活疫苗的可扩展性和有效性优势以及单循环复制的安全性优势。该系统由缺乏病毒必需糖蛋白基因的拉沙病毒复制子颗粒和表达糖蛋白产物的细胞系组成,从而能够有效地进行疫苗繁殖。用这些颗粒接种的豚鼠对接种物没有表现出临床反应,并且在感染拉沙病毒后对发热、体重减轻和致死性有保护作用。
Lassa fever is a viral zoonosis that can be transmitted from person to person, especially in the hospital setting. The disease is endemic to several countries in West Africa and can be a major contributor to morbidity and mortality in affected areas. There are no approved vaccines to prevent Lassa virus infection. In this work, we present a vaccine candidate that combines the scalability and efficacy benefits of a live vaccine with the safety benefits of single-cycle replication. The system consists of Lassa virus replicon particles devoid of the virus essential glycoprotein gene, and a cell line that expresses the glycoprotein products, enabling efficient vaccine propagation. Guinea pigs vaccinated with these particles showed no clinical reaction to the inoculum and were protected against fever, weight loss, and lethality after infection with Lassa virus.
DOI: 10.1128/jvi.00896-06
发表时间: 2006-09-01
影响因子: 5.4
作者:
Botten, Jason;Alexander, Jeff;Buchmeier, Michael J.
通讯作者: Buchmeier, Michael J.
DOI: 10.1128/jvi.78.6.2979-2983.2004
发表时间: 2004-03-01
影响因子: 5.4
作者:
Cornu, TI;Feldmann, H;de la Torre, JC
通讯作者: de la Torre, JC
DOI: 10.4269/ajtmh.1970.19.670
发表时间: 1970-01-01
影响因子: 3.3
作者:
FRAME, JD;BALDWIN, JM;TROUP, JM
通讯作者: TROUP, JM
DOI: 10.1177/0300985816677153
发表时间: 2017-05-01
影响因子: 2.4
作者:
Bell, T. M.;Shaia, C. I.;Cashman, K. A.
通讯作者: Cashman, K. A.
DOI: 10.1016/j.vaccine.2008.07.057
发表时间: 2008-09-26
期刊: Vaccine
影响因子: 5.5
作者:
Lukashevich IS;Carrion R Jr;Salvato MS;Mansfield K;Brasky K;Zapata J;Cairo C;Goicochea M;Hoosien GE;Ticer A;Bryant J;Davis H;Hammamieh R;Mayda M;Jett M;Patterson J
通讯作者: Patterson J